Fabien Le Bras

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy et al. · Blood · 2022 · 148 citations · Full text

Medicine, Immunology, Oncology +16

Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers

Gaëlle Fossard, Florence Broussais, Inês Coelho et al. · Annals of Oncology · 2017 · 140 citations · Full text

Medicine, Hematology, Oncology +11

A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis

Murielle Roussel, Giampaolo Merlini, Sylvie Chevret et al. · Blood · 2020 · 126 citations · Full text

Life Sciences, Clinical Sciences, Immunology +12

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

Camille Laurent, Alina Nicolae, Cécile Laurent et al. · Blood · 2019 · 121 citations · Full text

Life Sciences, Genetics, Molecular Biology +12

Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study

Jehan Dupuis, Franck Morschhauser, Hervé Ghesquières et al. · The Lancet Haematology · 2015 · 108 citations

Medicine, Oncology, Pharmacotherapy +9